UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 17, 2011
CytoDyn Inc.
(Exact name of registrant as specified in its charter)
| Colorado | 000-49908 | 75-3056237 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
1511 Third Street, Santa Fe, New Mexico 87505
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (505) 988-5520
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Effective as of March 17, 2011, Corinne E. Allen resigned as Chief Financial Officer and Vice President of CytoDyn Inc. (“CytoDyn”). CytoDyn is in the process of evaluating candidates to serve as its new Chief Financial Officer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CYTODYN INC. | ||||
| (Registrant) | ||||
| March 23, 2011 | By: | /s/ KENNETH J. VAN NESS | ||
| Kenneth J. Van Ness, | ||||
| President and Chief Executive Officer | ||||